Samsung Biologics
207940.KS
#428
Rank
S$62.20 B
Marketcap
$874.01
Share price
-1.16%
Change (1 day)
18.55%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): S$1.63 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are S$3.27 Billion. In 2023 the company made an earning of S$1.23 Billion, an increase over its 2022 earnings that were of S$1.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$1.63 B32.21%
2023 S$1.23 B9.77%
2022 S$1.12 B67.66%
2021 S$0.67 B103.97%
2020 S$0.32 B57.39%
2019 S$0.20 B-45.46%
2018 S$0.38 B-390%
2017 -S$0.14 Billion-46.74%
2016 -S$0.25 Billion